Serious infections with antirheumatic therapy: are biologicals worse? - Wikidata - awgldk - TriplyDB

Serious infections with antirheumatic therapy: are biologicals worse?

Serious infections with antirheumatic therapy: are biologicals worse?

http://www.wikidata.org/entity/Q35638259

about

Necrotizing fasciitis and septic shock related to the uncommon gram-negative pathogen Sphingobacterium multivorum Opioid Analgesics and the Risk of Serious Infections Among Patients With Rheumatoid Arthritis: A Self-Controlled Case Series Study.The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis.Rheumatoid lung disease Mycobacterial disease in patients with rheumatic disease."Serious skin & soft tissue infections in rheumatoid arthritis patients taking anti-tumor necrosis factor alpha drugs: a nested case-control study".Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy.Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells.Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort.

P2860

Q35668306-A037804E-574D-48D5-ADE6-13CE8A175556 Q36505715-5F580DF6-B23E-4CBA-ABD1-B5A294B09994 Q36761926-6014C101-1E4B-422F-BDF7-D57BB7586BFE Q37109233-AA353394-D588-49DD-8B57-A47146301787 Q37335860-CD9D236C-D31A-4DB0-A058-F1384A495E32 Q37343166-CDE2A119-2253-4734-9BF8-05745D0C435D Q38116751-23E31D3B-99E3-4759-A307-C8BC8CC64293 Q40716797-BD051A21-7203-42DA-9840-5808F9840669 Q45286659-68F084B9-6313-4D7F-9652-ED797F23B515

P2860

Serious infections with antirheumatic therapy: are biologicals worse?

http://www.wikidata.org/entity/Q35638259

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Serious infections with antirheumatic therapy: are biologicals worse?

@ast

Serious infections with antirheumatic therapy: are biologicals worse?

@en

type

label

Serious infections with antirheumatic therapy: are biologicals worse?

@ast

Serious infections with antirheumatic therapy: are biologicals worse?

@en

prefLabel

Serious infections with antirheumatic therapy: are biologicals worse?

@ast

Serious infections with antirheumatic therapy: are biologicals worse?

@en

P1433

Q35638259-5FC2B1F2-7433-4BA0-9E13-306D5C217422

P1476

Q35638259-B0F5CC9A-41EC-4EBB-B0B2-EA141F5458F3

P2093

Q35638259-2C751C21-A0CB-4277-BF1D-C4ECCAE384D4

P2860

Q35638259-0002B5DA-6443-43EA-9575-79FE7F99AA3A

Q35638259-04306771-8A17-415B-8134-31F047DEE31A

Q35638259-0A824EEA-F428-4003-8EB1-315E00FA0C56

Q35638259-0F64C2D1-9C6D-4E34-9FB7-98DD5BA11530

Q35638259-3A0025A3-E761-468B-8970-F4E755599D79

Q35638259-4230CB13-55D6-49B8-B4E0-3499CDB0AF8C

Q35638259-479B66F0-0CBB-4413-A260-76BEB82AEBAF

Q35638259-54E5302F-E8CF-45AF-BDDE-7B9A28669143

Q35638259-5E51AE00-3EBA-4481-BEFF-C1E561026079

Q35638259-61B9CCD0-1568-4BB8-A04B-88D8FC9B4AC6

P304

Q35638259-38A9A815-ED27-4070-9092-B5AEFB9831BB

P31

Q35638259-40EA2C08-2DD0-45C4-AA40-A5F4E9199945

P356

Q35638259-DFEA36A1-7BC8-4402-AAB8-34C8F3B517D7

P407

Q35638259-A82B28AC-75A8-4617-BF76-AF89E19BD1E4

P478

Q35638259-EBA2F3F2-412D-4760-879B-4544F895F527

P577

Q35638259-BE577C1A-44E2-48F1-824C-51C4A722FAF4

P5875

Q35638259-E142F708-070F-441E-B3DC-269429A0F6D5

P698

Q35638259-E3CA721F-0D9E-49C8-AE7B-C9C86CDCE1F7

P932

Q35638259-5A844962-5D5A-4144-95B8-D2E29ACA460B

P356

ARD.2006.058503

P1433

Annals of the Rheumatic Diseases

P1476

Serious infections with antirheumatic therapy: are biologicals worse?

@en

P2093

K L Winthrop

http://www.w3.org/2001/XMLSchema#string

P2860

Safety of extended treatment with anakinra in patients with rheumatoid arthritis

Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society

Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate

Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

Tumor necrosis factor alpha receptor I is important for survival from Streptococcus pneumoniae infections.

The mortality of rheumatoid arthritis.

Ten year mortality and causes of death in patients with rheumatoid arthritis.

Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.

P304

iii54-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.2006.058503

http://www.w3.org/2001/XMLSchema#string

P407

P478

65 Suppl 3

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6757855

http://www.w3.org/2001/XMLSchema#string

P698

17038474

http://www.w3.org/2001/XMLSchema#string

P932

1798385

http://www.w3.org/2001/XMLSchema#string